Michael W Ronellenfitsch

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 32

Top Venues

Cells

Cell death discovery

Cancers

International journal of molecular sciences

University Hospital Frankfurt, Goethe University

Bowling Green State University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital Frankfurt, Goethe University Aug 01 2018

Germany

Senior Physician Neurology :: Dr. Senckenberg Institute of Neurooncology, Department of Neurology

University Hospital Frankfurt, Goethe University Nov 01 2015

Germany

Head of Laboratory :: Dr. Senckenberg Institute of Neurooncology

Education History

Bowling Green State University Aug 01 2000 - Aug 31 2001

United States

MSC :: Department of Chemistry

Publications

Patrick N Harter, Katharina J Weber, Franz L Ricklefs, Richard Drexler, Ulrich Schüller, Marcel Hack, Tim Hanke, Hildegard Dohmen, Till Acker, Andreas von Deimling, Martin Hasselblatt, Iris Divé, Kristian Unger, Joachim P Steinbach, David Capper, Michael W Ronellenfitsch
Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation. Neuro-oncology advances 6 (1) (2024)
Raphael Reinecke, Kolja Jahnke, Martha Foltyn-Dumitru, Karsten Lachner, Moritz Armbrust, Katharina J Weber, Pia S Zeiner, Marcus Czabanka, Uta Brunnberg, Sylvia Hartmann, Joachim P Steinbach, Michael W Ronellenfitsch
Intrathecal IgM synthesis as a diagnostic marker in patients with suspected CNS lymphoma. Journal of neurochemistry 168 (6) (2024)
Benedikt Sauer, Nadja I Lorenz, Iris Divé, Kevin Klann, Anna-Luisa Luger, Hans Urban, Jan-Hendrik Schröder, Joachim P Steinbach, Christian Münch, Michael W Ronellenfitsch
Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell death. Cell death discovery 10 (1) (2024)
Kai Zhao, Madita Braun, Leonie Meyer, Katharina Otte, Hartmann Raifer, Frederik Helmprobst, Vincent Möschl, Axel Pagenstecher, Hans Urban, Michael W Ronellenfitsch, Joachim P Steinbach, Jelena Pesek, Bernhard Watzer, Wolfgang A Nockher, Regina Verena Taudte, Andreas Neubauer, Christopher Nimsky, Jörg Walter Bartsch, Tillmann Rusch
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1. Cells 13 (7) (2024)
Raphael Reinecke, Kolja Jahnke, Martha Foltyn-Dumitru, Karsten Lachner, Moritz Armbrust, Katharina J Weber, Pia S Zeiner, Marcus Czabanka, Uta Brunnberg, Sylvia Hartmann, Joachim P Steinbach, Michael W Ronellenfitsch
Intrathecal IgM synthesis as a diagnostic marker in patients with suspected CNS lymphoma. Journal of neurochemistry (2024)
Sven König, Florian Strassheimer, Nadja I Brandner, Jan-Hendrik Schröder, Hans Urban, Leander F Harwart, Stephanie Hehlgans, Joachim P Steinbach, Michael W Ronellenfitsch, Anna-Luisa Luger
Superoxide dismutase 1 mediates adaptation to the tumor microenvironment of glioma cells via mammalian target of rapamycin complex 1. Cell death discovery 10 (1) (2024)
Patrick N Harter, Katharina J Weber, Franz L Ricklefs, Richard Drexler, Ulrich Schüller, Marcel Hack, Tim Hanke, Hildegard Dohmen, Till Acker, Andreas von Deimling, Martin Hasselblatt, Iris Divé, Kristian Unger, Joachim P Steinbach, David Capper, Michael W Ronellenfitsch
Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation. Neuro-oncology advances 6 (1) (2024)
Benedikt Sauer, Nadja I Lorenz, Iris Divé, Kevin Klann, Anna-Luisa Luger, Hans Urban, Jan-Hendrik Schröder, Joachim P Steinbach, Christian Münch, Michael W Ronellenfitsch
Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell death. Cell death discovery 10 (1) (2024)
Kai Zhao, Madita Braun, Leonie Meyer, Katharina Otte, Hartmann Raifer, Frederik Helmprobst, Vincent Möschl, Axel Pagenstecher, Hans Urban, Michael W Ronellenfitsch, Joachim P Steinbach, Jelena Pesek, Bernhard Watzer, Wolfgang A Nockher, Regina Verena Taudte, Andreas Neubauer, Christopher Nimsky, Jörg Walter Bartsch, Tillmann Rusch
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1. Cells 13 (7) (2024)
Kai Zhao, Madita Braun, Leonie Meyer, Katharina Otte, Hartmann Raifer, Frederik Helmprobst, Vincent Möschl, Axel Pagenstecher, Hans Urban, Michael W Ronellenfitsch, Joachim P Steinbach, Jelena Pesek, Bernhard Watzer, Wolfgang A Nockher, Regina Verena Taudte, Andreas Neubauer, Christopher Nimsky, Jörg Walter Bartsch, Tillmann Rusch
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1. Cells 13 (7) (2024)
Kai Zhao, Madita Braun, Leonie Meyer, Katharina Otte, Hartmann Raifer, Frederik Helmprobst, Vincent Möschl, Axel Pagenstecher, Hans Urban, Michael W Ronellenfitsch, Joachim P Steinbach, Jelena Pesek, Bernhard Watzer, Wolfgang A Nockher, Regina Verena Taudte, Andreas Neubauer, Christopher Nimsky, Jörg Walter Bartsch, Tillmann Rusch
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1. Cells 13 (7) (2024)
Kai Zhao, Madita Braun, Leonie Meyer, Katharina Otte, Hartmann Raifer, Frederik Helmprobst, Vincent Möschl, Axel Pagenstecher, Hans Urban, Michael W Ronellenfitsch, Joachim P Steinbach, Jelena Pesek, Bernhard Watzer, Wolfgang A Nockher, Regina Verena Taudte, Andreas Neubauer, Christopher Nimsky, Jörg Walter Bartsch, Tillmann Rusch
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1. Cells 13 (7) (2024)
Sven König, Florian Strassheimer, Nadja I Brandner, Jan-Hendrik Schröder, Hans Urban, Leander F Harwart, Stephanie Hehlgans, Joachim P Steinbach, Michael W Ronellenfitsch, Anna-Luisa Luger
Superoxide dismutase 1 mediates adaptation to the tumor microenvironment of glioma cells via mammalian target of rapamycin complex 1. Cell death discovery 10 (1) (2024)
Peter Baumgarten, Georg Prange, Marcel A Kamp, Daniel Monden, Vanessa Neef, Franziska Schwarzer, Daniel Dubinski, Nazife Dinc, Katharina J Weber, Markus Czabanka, Elke Hattingen, Michael W Ronellenfitsch, Joachim P Steinbach, Christian Senft
Treatment of very elderly glioblastoma patients ≥ 75 years of age: whom to treat. Journal of neuro-oncology (2023)
Pia S Zeiner, Katharina Filipski, Natalie Filmann, Marie-Thérèse Forster, Martin Voss, Emmanouil Fokas, Ulrich Herrlinger, Patrick N Harter, Joachim P Steinbach, Michael W Ronellenfitsch
Sex-Dependent Analysis of Temozolomide-Induced Myelosuppression and Effects on Survival in a Large Real-life Cohort of Patients With Glioma. Neurology 98 (20) (2022)
Anna-Luisa Luger, Sven König, Patrick Felix Samp, Hans Urban, Iris Divé, Michael C Burger, Martin Voss, Kea Franz, Emmanouil Fokas, Katharina Filipski, Melanie-Christin Demes, Albrecht Stenzinger, Felix Sahm, David E Reuss, Patrick N Harter, Sebastian A Wagner, Elke Hattingen, Jennifer Wichert, Constantin Lapa, Stefan Fröhling, Joachim P Steinbach, Michael W Ronellenfitsch
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis. Journal of neuro-oncology 159 (2) (2022)
Agnes Koch, Stefan Sponholz, Stephan Trainer, Jan Stratmann, Martin Sebastian, Maximilian Rauch, Robert Wolff, Joachim P Steinbach, Michael W Ronellenfitsch, Hans Urban
Pulmonary Resection after Radiosurgery and Neoadjuvant Immunochemotherapy for NSCLC Patients with Synchronous Brain Metastasis-A Case Series of Three Patients. Current oncology (Toronto, Ont.) 29 (4) (2022)
Vanessa Neef, Sven König, Daniel Monden, Daniel Dubinski, Anika Benesch, Florian Jürgen Raimann, Florian Piekarski, Michael W Ronellenfitsch, Patrick N Harter, Christian Senft, Patrick Meybohm, Elke Hattingen, Kai Zacharowski, Volker Seifert, Peter Baumgarten
Clinical Outcome and Risk Factors of Red Blood Cell Transfusion in Patients Undergoing Elective Primary Meningioma Resection. Cancers 13 (14) (2021)
Pia S Zeiner, Leonhard Mann, Katharina Filipski, Tatjana Starzetz, Marie-Therese Forster, Michael W Ronellenfitsch, Joachim P Steinbach, Michel Mittelbronn, Marlies Wagner, Patrick N Harter
Immune profile and radiological characteristics of progressive multifocal leukoencephalopathy. European journal of neurology (2021)
Cedric Tehranian, Laura Fankhauser, Patrick N Harter, Colin D H Ratcliffe, Pia S Zeiner, Julia M Messmer, Dirk C Hoffmann, Katharina Frey, Dana Westphal, Michael W Ronellenfitsch, Erik Sahai, Wolfgang Wick, Matthia A Karreman, Frank Winkler
The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis. Neuro-oncology (2021)
Martin Voss, Katharina Johanna Wenger, Nina von Mettenheim, Jörg Bojunga, Manuela Vetter, Bianca Diehl, Kea Franz, Ruediger Gerlach, Michael W Ronellenfitsch, Patrick N Harter, Elke Hattingen, Joachim P Steinbach, Claus Rödel, Johannes Rieger
Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial. European journal of nutrition (2021)
Martin Voss, Katharina Johanna Wenger, Emmanouil Fokas, Marie-Therese Forster, Joachim P Steinbach, Michael W Ronellenfitsch
Single-shot bevacizumab for cerebral radiation injury. BMC neurology 21 (1) (2021)
Anna-Luisa Luger, Nadja I Lorenz, Hans Urban, Iris Divé, Anna L Engel, Florian Strassheimer, Katja Dettmer, Pia S Zeiner, Shabnam Shaid, Nina Struve, Malte Kriegs, Ute Hofmann, Peter J Oefner, Patrick N Harter, Joachim P Steinbach, Michael W Ronellenfitsch
Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death. Cancers 12 (8) (2020)
Hans Urban, Gabriele D Maurer, Anna-Luisa Luger, Nadja I Lorenz, Benedikt Sauer, Christopher Stroh, Jörg Trojan, Michel Mittelbronn, Joachim P Steinbach, Patrick N Harter, Michael W Ronellenfitsch
Cetuximab-Mediated Protection from Hypoxia- Induced Cell Death: Implications for Therapy Sequence in Colorectal Cancer. Cancers 12 (10) (2020)
Martin Voss, AbdulAziz Batarfi, Eike Steidl, Marlies Wagner, Marie-Thérèse Forster, Joachim P Steinbach, Claus M Rödel, Jörg Bojunga, Michael W Ronellenfitsch
Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab. Journal of clinical medicine 8 (10) (2019)
Dennis Heinzen, Iris Divé, Nadja I Lorenz, Anna-Luisa Luger, Joachim P Steinbach, Michael W Ronellenfitsch
Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma Treatment. International journal of molecular sciences 20 (18) (2019)
Martha Foltyn, Anna-Luisa Luger, Nadja I Lorenz, Benedikt Sauer, Michel Mittelbronn, Patrick N Harter, Joachim P Steinbach, Michael W Ronellenfitsch
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma. British journal of cancer 120 (5) (2019)
Martin Voss, Nadja I Lorenz, Anna-Luisa Luger, Joachim P Steinbach, Johannes Rieger, Michael W Ronellenfitsch
Rescue of 2-Deoxyglucose Side Effects by Ketogenic Diet. International journal of molecular sciences 19 (8) (2018)
Ines Bruns, Benedikt Sauer, Michael C Burger, Jule Eriksson, Ute Hofmann, Yannick Braun, Patrick N Harter, Anna-Luisa Luger, Michael W Ronellenfitsch, Joachim P Steinbach, Johannes Rieger
Disruption of peroxisome proliferator-activated receptor γ coactivator (PGC)-1α reverts key features of the neoplastic phenotype of glioma cells. The Journal of biological chemistry 294 (9) (2018)
Michael W Ronellenfitsch, Pia S Zeiner, Michel Mittelbronn, Hans Urban, Torsten Pietsch, Dirk Reuter, Christian Senft, Joachim P Steinbach, Manfred Westphal, Patrick N Harter
Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma. Acta neuropathologica communications 6 (1) (2018)
Anna-Luisa Luger, Benedikt Sauer, Nadja I Lorenz, Anna L Engel, Yannick Braun, Martin Voss, Patrick N Harter, Joachim P Steinbach, Michael W Ronellenfitsch
Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible Systems. International journal of molecular sciences 19 (5) (2018)
Michael W Ronellenfitsch, Ji-Eun Oh, Kaishi Satomi, Koichiro Sumi, Patrick N Harter, Joachim P Steinbach, Jörg Felsberg, David Capper, Catherine Voegele, Geoffroy Durand, James McKay, Florence Le Calvez-Kelm, Jens Schittenhelm, Barbara Klink, Michel Mittelbronn, Hiroko Ohgaki
CASP9 germline mutation in a family with multiple brain tumors. Brain pathology (Zurich, Switzerland) 28 (1) (2017)

Michael W Ronellenfitsch.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Michael W Ronellenfitsch